Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies
about
Use of Genomic Tools to Improve Cattle Health in the Context of Infectious DiseasesA bovine respiratory syncytial virus model with high clinical expression in calves with specific passive immunityPartial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.RNA-based viral vectors.New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine.Protection of calves by a prefusion-stabilized bovine RSV F vaccine.Proteome analysis of bronchoalveolar lavage from calves infected with bovine respiratory syncytial virus-Insights in pathogenesis and perspectives for new treatments.Genetic characterization of bovine respiratory syncytial virus strains isolated in Italy: evidence for the circulation of new divergent clades.
P2860
Q26750962-D7443069-4848-4A82-8F26-DACA7EF10C62Q35225718-3F1ACA4C-BB96-42E9-884C-3C8697E73372Q35913930-F5AB6336-3249-4EE2-AB02-1C355C85BEE8Q38266413-45ECA6E8-1A3B-4625-9B94-19AEDEC8FB6CQ38628928-ADA1F549-ABD2-4E11-BCFC-630DFD1430E4Q38660842-6D399B61-6AFF-49E1-BE95-0173A16F48BFQ40565908-2148D7E6-EB84-4A19-8471-849828C234B5Q41918616-08490B86-D6A2-4D0E-98A7-257429AA54E5Q42696040-D86F944A-4174-49B1-8334-21586B68DD63Q47282089-DB078308-9084-4423-BE8C-6427051B29F5
P2860
Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vaccine safety and efficacy ev ...... alves with maternal antibodies
@ast
Vaccine safety and efficacy ev ...... alves with maternal antibodies
@en
Vaccine safety and efficacy ev ...... alves with maternal antibodies
@nl
type
label
Vaccine safety and efficacy ev ...... alves with maternal antibodies
@ast
Vaccine safety and efficacy ev ...... alves with maternal antibodies
@en
Vaccine safety and efficacy ev ...... alves with maternal antibodies
@nl
prefLabel
Vaccine safety and efficacy ev ...... alves with maternal antibodies
@ast
Vaccine safety and efficacy ev ...... alves with maternal antibodies
@en
Vaccine safety and efficacy ev ...... alves with maternal antibodies
@nl
P2093
P2860
P50
P1433
P1476
Vaccine safety and efficacy ev ...... alves with maternal antibodies
@en
P2093
Boby Makabi-Panzu
Catherine Dubuquoy
Erika Karlstam
Geraldine Taylor
Jean-Louis Roque
Krister Blodörn
Michelle Thom
Per Karlsson
Sabine Riffault
P2860
P304
P356
10.1371/JOURNAL.PONE.0100392
P407
P577
2014-06-19T00:00:00Z